Band-like sensory disturbance around the trunk is characteristic of which myelopathy, and if non‑compressive what is the usual cause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Band-Like Sensation in Myelopathy

A band-like sensory disturbance around the trunk is characteristic of thoracic myelopathy, and when non-compressive, the most common causes are demyelinating diseases (particularly multiple sclerosis), spinal cord ischemia, or metabolic myelopathies such as vitamin B12 deficiency. 1, 2

Anatomical Localization

  • Band-like sensations (also called sensory levels) typically indicate thoracic spinal cord pathology, as the dermatomal distribution creates a circumferential pattern around the trunk 3
  • The sensory level corresponds to the highest level of spinal cord dysfunction, though false localizing sensory levels can occur 4
  • Cervical myelopathy can paradoxically present with thoracic sensory levels (T4-T10), creating diagnostic confusion and potentially delaying appropriate treatment 4

Critical Pitfall

  • Do not assume a thoracic sensory level always indicates thoracic cord pathology - cervical compression can produce false localizing thoracic sensory levels in up to 4 documented cases, with persistence of these levels even after successful cervical decompression surgery 4
  • Always image the cervical spine with MRI even when clinical examination suggests a thoracic level 4

Non-Compressive Causes

Demyelinating Disease (Most Common Non-Compressive Etiology)

  • Multiple sclerosis involves the spinal cord in 80-90% of patients, most commonly affecting the cervical cord, though thoracic involvement produces the classic band-like sensation 1, 2
  • MS spinal cord lesions are typically small (≤2 vertebral segments), peripherally located in lateral and posterior columns, and wedge-shaped on axial imaging 1
  • Neuromyelitis optica (NMO) causes longitudinally extensive transverse myelitis (≥3 vertebral segments) with cloud-like enhancement patterns, distinguishing it from MS 1, 2

Vascular Causes

  • Spinal cord ischemia results from atheromatous disease, aortic surgery complications, systemic hypotension, or fibrocartilaginous embolic disease 2
  • Spinal arteriovenous malformations cause progressive myelopathy through venous hypertension, with characteristic dorsal cord edema and enlarged veins 1, 2

Metabolic Causes

  • Vitamin B12 deficiency produces subacute combined degeneration with characteristic posterior and lateral column involvement 1, 2, 3
  • Copper deficiency myelopathy presents similarly to B12 deficiency 2, 3

Infectious Causes

  • Human T-cell lymphotropic virus myelitis, tuberculosis, HIV vacuolar myelopathy, and schistosomiasis can all produce non-compressive myelopathy with band-like sensations 1, 2, 3

Diagnostic Approach

  • MRI without and with IV contrast is essential to distinguish compressive from non-compressive etiologies and evaluate for inflammatory, infectious, or neoplastic causes 1, 3
  • Contrast enhancement patterns help differentiate etiologies: pancake-like enhancement suggests spondylotic myelopathy 1, 5, cloud-like enhancement suggests NMO 1, and band-like enhancement suggests Balo concentric sclerosis 1
  • Diffusion-weighted imaging should be included when spinal cord ischemia is suspected, as it shows signal changes earlier than T2-weighted sequences 1

Imaging Characteristics by Etiology

  • MS lesions: Small, focal, peripherally located, wedge-shaped on axial views 1
  • NMO lesions: Longitudinally extensive (≥3 segments), central gray matter involvement, cloud-like enhancement 1
  • Metabolic myelopathy: Posterior and lateral column T2 hyperintensity without enhancement 1
  • Ischemic myelopathy: Central gray matter involvement (owl's eyes sign), restricted diffusion 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Causes and Clinical Context of Myelopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Myelopathy Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the diagnosis and treatment for idiopathic cervical myelopathy in a male adult from India?
What is the management for a patient with MRI cervical spine showing cervical spondylosis, C3-C4 mild disc bulge, C4-C5 grade 1 stenosis, C5-C6 grade 2 stenosis with bilateral exiting nerve root impingement, and C6-C7 grade 1 stenosis with bilateral exiting nerve root impingement?
What is the next step for a 55-year-old male with a hard palpable mass in the right neck region and ultrasound findings of a prominent cervical vertebrae?
Can cervical myelopathy cause bilateral feet paresthesia at the soles?
What is the recommended treatment for a patient with neck and shoulder pain and an MRI showing cervical spine degeneration without acute processes, including mild to moderate neural foraminal stenosis and uncovertebral spurring at multiple levels?
How should I manage a patient whose urinalysis shows nitrite positive but leukocyte esterase negative?
How should I manage an intubated adult ICU patient with ventilator‑associated pneumonia, a small but increasing pleural effusion, and new tachypnea?
In a pregnant woman with a singleton gestation, when and how should first‑trimester screening for aneuploidy be offered, and what follow‑up steps are recommended if the calculated risk is elevated?
What is the differential diagnosis, work‑up and initial management for a 63‑year‑old man with generalized peripheral numbness from arms to feet, no focal neurological deficits, mild diastolic hypertension and mild hypothermia, and a history of allergy treated with cetirizine?
Can a woman who is eight months pregnant (≈32 weeks gestation) safely take carbimazole for hyperthyroidism?
What is the recommended denosumab (Xgeva) dosing schedule for severe or refractory hypercalcemia (e.g., malignancy‑related or when bisphosphonates are contraindicated due to renal insufficiency), how should calcium, phosphate, creatinine and vitamin D be monitored, and what are the alternative therapies if denosumab cannot be used?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.